Active ingredient
Pemigatinib
3 finished FDA listings contain Pemigatinib as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- PEMIGATINIB
- Dosage forms
- Tablet
- Routes
- Oral
- Manufacturers / labelers
- 1
- Strengths listed
- 13.5 mg/1 · 4.5 mg/1 · 9 mg/1
- Brand names in FDA listings
- Pemazyre
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 2359268
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| NDA 213736 | INCYTE CORP | 2020-04-17 | 3 |
Official labeling on DailyMed
- PEMAZYRE (PEMIGATINIB) TABLET [INCYTE CORPORATION] · version 17 · 2026-06-15
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.